H. Fredholm

Local Recurrence after Treatment of Ductal Carcinoma In Situ: A Comprehensive Overview.

I. Fredriksson, Amelia Chiorescu, H. Fredholm, 2021, Chirurgia.

The Natural History of Ductal Carcinoma In Situ of the Breast - An Overview.

I. Fredriksson, Amelia Chiorescu, H. Fredholm, 2021, Chirurgia.

97O PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels

J. Bjöhle, A. Bosch, Y. Brandberg, 2020 .

Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment

L. Holmberg, H. Lindman, J. Frisell, 2009, PloS one.

Breast cancer in young women : aspects on mortality and local recurrence

H. Fredholm, 2017 .

Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma

U. Lindforss, H. Olivecrona, N. Papadogiannakis, 2000, Cancer.

Long-term outcome in young women with breast cancer: a population-based study

L. Holmberg, J. Bergh, F. Pontén, 2016, Breast Cancer Research and Treatment.

Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: Results from the Swedish PREDIX HER2 trial identifying a new potential de-escalation standard?

J. Bergh, J. Bjöhle, A. Bosch, 2019, Journal of Clinical Oncology.

Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial.

J. Bergh, J. Hartman, J. Bjöhle, 2021, JAMA oncology.

OptiBra study, a randomized controlled trial on optimal postoperative bra support after breast cancer surgery.

H. Johansson, I. Fredriksson, H. Fredholm, 2023, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

Breast cancer in young women and prognosis: How important are proliferation markers?

L. Holmberg, J. Bergh, F. Pontén, 2017, European journal of cancer.